1、 Medical Devices Report Code:GDME7738FSA Published:August 2024 Insulet Corp(PODD)-Financial and Strategic SWOT Analysis Review Insulet Corp(PODD)-Financial and Strategic SWOT Analysis Review Report Code:GDME7738FSA Published:August 2024 GlobalData 2024.This product is licensed and is not to be photo

2、copied.Page 2 Company Snapshot 100 Nagog Park Phone+1 978 6007000 Revenue 1,697.1(million USD)Acton,MA Fax+1 978 6000120 Net Profit 206.30(million USD)01720-3440 Website Employees 3,000 United States Exchange PODD NASDAQ Industry Medical Equipment Company Overview Insulet Corp(Insulet)is a medical d

3、evice company that develops,manufactures and distributes insulin management systems for diabetic patients.Its insulin management system,OmniPod,is a continuous insulin delivery system for insulin-dependent diabetics.The OmniPod system consists of a disposable self-adhesive tubeless insulin infusion

4、device,and a handheld wireless device,Personal Diabetes Manager.The company also works in partnership with various biotechnology and pharmaceutical companies that use the customized form of its OmniPod system to deliver drugs at specified intervals at predetermined doses.Key Executives Name Title Ja

5、mes R.Hollingshead Chief Executive Officer Timothy J.Scannell Director Jessica Hopfield,Ph.D.Director Michael R.Minogue Director Wayne A.I.Frederick,M.D.Director Source:Annual Report,Company Website,Primary and Secondary Research,GlobalData Share Data Insulet Corp Share Price(USD)as on 31-Jul-2024 1

6、94.40 EPS(USD)2.94 Market Cap(million USD)13,612 Enterprise Value(million USD)14,304 Shares Outstanding(million)70 Source:Annual Report,Company Website,Primary and Secondary Research,GlobalData SWOT Analysis Insulet Corp,SWOT Analysis Strengths Weaknesses Focus on R&D Activities Proprietary OmniPod